Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.52 USD | -1.94% | -3.86% | +23.62% |
05-13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MYRIAD GENETICS, INC. | Diagnostic & Testing Substances | -1.38% | -3.86% | +23.62% | +4.32% | -1.99% | 2.17B |
- Stock Market
- Equities
- MYGN Stock
- Charts Myriad Genetics, Inc.
- Relative Strength Chart